Citations

Showing 10 of 108152 citations.

Glycemic Control and Survival of Patients With Coexisting Diabetes Mellitus and Gastric Or Esophageal Cancer
Karlin, Nina J. , Buras, Matthew , Verona, Patricia M , Cook, Curtiss B. , Buras, Matthew R , Kosiorek, Heidi

Mayo Clinic

Future Science OA | June 26, 2019 | Volume: 5 | Issue: 6 | Pages: No page available

10.2144/fsoa-2019-0038 | PMID 31285842 Get It

Endothelial Dysfunction
Lerman, Lilach O. , Corban, Michel , Lerman, Amir

Mayo Clinic

Arteriosclerosis, Thrombosis, and Vascular Biology | June 26, 2019 | Volume: 39 | Issue: 7 | Pages: 1272-1274

10.1161/atvbaha.119.312836 | PMID 31242027 Get It

Multicenter Investigation of Fungal Infections of Inflatable Penile Prostheses
Gross, Martin , Reinstatler, Lael , Henry, Gérard , Honig, Stanton, Stahl, Peter J., Maria, Pedro , Bennett, Nelson , Kava, Bruce, Köhler, Tobias , Beilan, Jonathan , Carrión, Rafael , Munarriz, Ricardo , Burnett, Arthur L. “Bud”

Mayo Clinic

The Journal of Sexual Medicine | June 26, 2019 | Volume: 16 | Issue: 7 | Pages: 1100-1105

10.1016/j.jsxm.2019.05.003 | PMID 31255212 Get It

Abstract Background Fungal infections of inflatable penile prostheses (IPPs) are inadequately understood in the literature. Aim To review a multi-institution database of IPP infections to examine for common patient and surgical factors related to IPP fungal infections. Methods This is a retrospective Institutional Review Board–approved analysis of 217 patients at 26 institutions who underwent salvage or device explant between 2001 and 2018. Patient data were compiled after an extensive record review. Outcomes 26 patients (12%) with fungal infections were identified. Results 23 of 26 patients (83%) with a fungal IPP infection were either diabetic or overweight. 15 patients had undergone primary IPP implantation, and the other 11 had previously undergone an average of 1.7 IPP-related surgeries (range 1–3; median 2). The average age at implantation was 63 years (range 31–92; median 63). 18 of the 26 patients with fungal infection had diabetes (69%), with a mean hemoglobin A1c (HbA1c) value of 8.4 (range 5.8–13.3; median 7.5). Twenty-two patients (85%) were overweight or obese. The mean body mass index for all patients was 30.1 kg/m2 (range 23.7–45 kg/m2; median 28.4 kg/m2), and that for diabetic patients was 30.8 kg/m2 (range 24.1–45 kg/m2, median 29.7 kg/m2). Ninety-one percent of implants were placed with intravenous antibiotics, consistent with current American Urological Association guidelines: an aminoglycoside plus first- or second-generation cephalosporin or vancomycin or ampicillin/sulbactam or piperacillin/tazobactam. 65% (17 of 26) of infected IPPs had only fungal growth in culture. No patient had concomitant immunosuppressive disease or recent antibiotic exposure before IPP implantation. Clinical Implications More than two-thirds of the fungal infections occurred in diabetic patients and 85% occurred in overweight or obese patients, suggesting that antifungal prophylaxis may be appropriate in these patients. Strengths & Limitations This is the largest series of fungal infections reported to date in the penile prosthesis literature. The overall number of such cases, however, remains small. Conclusion Fungal infections represent 12% of all penile prosthesis infections in our series and were seen mostly in diabetic or overweight patients, who may benefit from antifungal prophylaxis.
Molecular characterization of known and novel ACVR1 variants in phenotypes of aberrant ossification
Gupta, Aditi , Zimmermann, Michael T. , Sigafoos, Ashley N. , Macklin, Sarah , Pignolo, Robert J. , Klee, Eric W. , Macklin, Sarah K, Urrutia, Raul A, Zimmermann, Michael T , Wang, Haitao , Broski, Stephen M. , Urrutia, Raúl , Clark, Karl J. , Atwal, Paldeep S

Mayo Clinic

American Journal of Medical Genetics Part A | June 26, 2019 | Volume: 179 | Issue: 9 | Pages: 1764-1777

10.1002/ajmg.a.61274 | PMID 31240838 Get It

AbstractDiffuse idiopathic skeletal hyperostosis (DISH) is a disorder principally characterized by calcification and ossification of spinal ligaments and entheses. Fibrodysplasia ossificans progressiva (FOP) is a rare autosomal dominant disabling disorder characterized by progressive ossification of skeletal muscle, fascia, tendons, and ligaments. These conditions manifest phenotypic overlap in the ossification of tendons and ligaments. We describe herein a patient with DISH, exhibiting heterotopic ossification of the posterior longitudinal ligament where clinical whole exome sequencing identified a variant within ACVR1, a gene implicated in FOP. This variant, p.K400E, is a novel variant, not identified previously, and occurs in a highly conserved region across orthologs. We used sequence‐based predicative algorithms, molecular modeling, and molecular dynamics simulations, to test the potential for p.K400E to alter the structure and dynamics of ACVR1. We applied the same modeling and simulation methods to established FOP variants, to identify the detailed effects that they have on the ACVR1 protein, as well as to act as positive controls against which the effects of p.K400E could be evaluated. Our in silico molecular analyses support p.K400E as altering the behavior of ACVR1. In addition, functional testing to measure the effect of this variant on BMP‐pSMAD 1/5/8 target genes was carried out which revealed this variant to cause increased ID1 and Msx2 expression compared with the wild‐type receptor. This analysis supports the potential for the variant of uncertain significance to contribute to the patient's phenotype.
Upper and lower thresholds of fat-free mass index in a large cohort of female collegiate athletes
Harty, Patrick S. , Zabriskie, Hannah A. , Stecker, Richard A., Currier, Brad S. , Moon, Jessica M. , Kerksick, Chad M. , Jagim, Andrew R , Kerksick, Chad M , Harty, Patrick S , Zabriskie, Hannah A , Currier, Bradley S , Jagim, Andrew R.

Mayo Clinic

Journal of Sports Sciences | June 26, 2019 | Volume: 37 | Issue: 20 | Pages: 2381-2388

10.1080/02640414.2019.1634964 | PMID 31238804 Get It

Stem Cell-Related Studies and Stem Cell-Based Therapies in Liver Diseases
Zhou, Wei , Nelson, Erek , Rmilah, Anan Abu , Amiot, Bruce , Nyberg, Scott L. , Nelson, Erek D, Abu Rmilah, Anan A, Amiot, Bruce P, Zhou, Wei

Mayo Clinic

Cell Transplantation | June 26, 2019 | Volume: 28 | Issue: 9-10 | Pages: 1116-1122

10.1177/0963689719859262 | PMID 31240944 Get It

Owing to the increasing worldwide burden of liver diseases, the crucial need for safe and effective interventions for treating end-stage liver failure has been a very productive line of inquiry in the discipline of hepatology for many years. Liver transplantation is recognized as the most effective treatment for end-stage liver disease; however, the shortage of donor organs, high medical costs, and lifelong use of immunosuppressive agents represent major drawbacks and demand exploration for alternative treatments. Stem cell-based therapies have been widely studied in the field of liver diseases and are considered to be among the most promising therapies. Herein, we review recent advances in the application of stem cell-related therapies in liver disease with the aim of providing readers with relevant knowledge in this field and inspiration to spur further inquiry.
Selective brain hypothermia: feasibility and safety study of a novel method in five patients
Seyedsaadat, Seyed Mohammad , Marasco, Silvana , Daly, David , McEgan, R., Anderson, James L., Rodgers, Seth, Kreck, Thomas, Kadirvel, Ramanathan , Kallmes, David F. , Daly, David , Anderson, James

Mayo Clinic

Perfusion | June 26, 2019 | Volume: 35 | Issue: 2 | Pages: 96-103

10.1177/0267659119853950 | PMID 31238794 Get It

Background/objective: Reduction of brain temperature remains the most common method of neuroprotection against ischemic injury employed during cardiac surgery. However, cooling delivered via the cardiopulmonary bypass circuit is brief and cooling the body core along with the brain has been associated with a variety of unwanted effects. This study investigated the feasibility and safety of a novel selective brain cooling approach to induce rapid, brain-targeted hypothermia independent of the cardiopulmonary bypass circuit. Methods: This first-in-human feasibility study enrolled five adults undergoing aortic valve replacement with cardiopulmonary bypass support. During surgery, the NeuroSave system circulated chilled saline within the pharynx and upper esophagus. Brain and body core temperature were continuously monitored. Adverse effects, cardiopulmonary function, and device function were noted. Results: Patient 1 received cooling fluid for an insignificant period, and Patients 2-5 successfully underwent the cooling procedure using the NeuroSave system for 56-89 minutes. Cooling fluid was 12°C for Patients 1-3, 6°C for Patient 4, and 2°C for Patient 5. There were no NeuroSave-related adverse events and no alterations in cardiopulmonary function during NeuroSave use. Brain temperature decreased by 3°C within 15 minutes and remained at least 3.5°C colder than the body core. During a brief episode of hypotension in one patient, the brain cooled an additional 4°C in 2 minutes, briefly reaching 27.4°C. Conclusion: The NeuroSave system can induce rapid brain-targeted hypothermia and simultaneously maintain a favorable body–brain temperature gradient, even during hypotension. Further studies are required to evaluate the function of the system during longer periods of use.
CHOROIDAL NEOVASCULARIZATION AND CHORIORETINAL ATROPHY IN A PATIENT WITH MELANOMA-ASSOCIATED RETINOPATHY AFTER IPILIMUMAB/NIVOLUMAB COMBINATION THERAPY
Elwood, Kevin F., Pulido, José S. , Day, Shelley , Harper, C. Armitage , Wong, Robert W.

Mayo Clinic

RETINAL Cases & Brief Reports | June 26, 2019 | Volume: 15 | Issue: 5 | Pages: 514-518

10.1097/icb.0000000000000882 | PMID 31246886 Get It

Purpose: To describe a case of choroidal neovascularization (CNV) and chorioretinal scarring in a patient with melanoma-associated retinopathy after ipilimumab/nivolumab combination immune therapy for malignant melanoma. Methods: Retrospective case report with fundus photography, fluorescein angiography, optical coherence tomography, and electroretinography. Results: A 65-year-old woman presented with symptoms of photopsia and visual field loss. She had previously undergone ipilimumab/nivolumab combination chemotherapy treatment for malignant melanoma 14 months earlier coinciding with the onset of her visual symptoms. Fundus photography showed bilateral atrophic chorioretinal lesions and peripheral retinal pigment epithelial changes. Fluorescein angiography revealed retinovascular leakage in both eyes with CNV in the right eye. Optical coherence tomography showed a pigment epithelial detachment with subretinal fluid and subretinal hyperreflective material consistent with occult CNV. Visual field testing showed generalized visual field loss in both eyes. Bloodwork discovered an elevated angiotensin-converting enzyme. Electroretinography revealed abnormal peripheral rod and cone function with impairment of the photoreceptor and inner nuclear layer. Serum Western blot was positive for 60 kDa antiretinal autoantibody. After a single bevacizumab injection in the right eye, CNV resolved and visual acuity improved from 20/50 before the injection to 20/25 3 months after the injection. Visual acuity in the left eye deteriorated for months to counting fingers but then improved to 20/100 on follow-up examinations. Conclusion: Ipilimumab and nivolumab have been associated with immune-related ocular adverse effects. We report a case of combination therapy presenting with chorioretinal scarring and subsequent CNV in a patient with melanoma-associated retinopathy, a rare yet important adverse effect.
A Lot of Progress, With More to Be Done: A Response to NIH Pathways to Prevention Report “Research Gaps for Long-Term Drug Therapies for Osteoporotic Fracture Prevention”
Shane, Elizabeth , Khosla, Sundeep , Clarke, Bart L, Khosla, Sundeep , Leder, Benjamin Z. , Clarke, B.L. , Kiel, Douglas P.

Mayo Clinic

Journal of Bone and Mineral Research | June 25, 2019 | Volume: 34 | Issue: 9 | Pages: 1549-1551

10.1002/jbmr.3823 | PMID 31237962 Get It

ABSTRACT The public health implications of osteoporosis are enormous but the disease remains underdiagnosed and undertreated. In October 2018, the National Institutes of Health (NIH) convened a Pathways to Prevention (P2P) Workshop entitled “Appropriate Use of Drug Therapies for Osteoporotic Fracture Prevention” designed to identify research gaps, suggest future research opportunities, and advance the field through an evidence-based assessment. By design, the P2P report focused on “gaps” in our knowledge base. Unfortunately, however, the report did not sufficiently acknowledge the current evidence that unequivocally demonstrates the therapeutic efficacy of existing pharmacologic therapies for osteoporosis, which has the potential to exacerbate the current crises in osteoporosis diagnosis and treatment. © 2019 American Society for Bone and Mineral Research.